Scientific context. Not medical advice.
VESTRIKSCIENCE. STRUCTURE. TRACEABILITY.
Search
Menu

Research catalogue

TESAMORELIN – vial

GHRH analogue peptide

  • Endocrine research
  • Lipid metabolism research

Substance research context; not a claim of efficacy or approval for this product.

Scientific profile and evidence limitations

€30,00

Scientific context. Not medical advice.

Availability
In stock

A Shopify discount is configured for 3 or more units of this same product; its variants may be combined. Purchasing is unavailable. The regular price is shown; Shopify calculates actual discounts.

Cart

Purchasing and payment are unavailable. Catalogue products are out of stock.

Planned offers · inactive

€100 qualifying merchandise value → 1 BAC Water gift. Gift inactive: stock is 0, publication and gift terms are unapproved.

Free shipping to served EU destinations from €250 merchandise value after discounts. Below the threshold: Lithuania €5.99, the 12 newly served EU countries €15, the other 14 EU countries €17. Outside the EU, shipping remains paid at every order value.

This is a rate preview, not a confirmed delivery address. Ordering is unavailable. Gift inactive; 15% quantity rules are configured for the 13 peptide products only. Countries and shipping information.

Laboratory accessories

Full cart page

Product overview

TESAMORELIN catalogue record. Form: vial. Declared catalogue quantities: 5mg.

Product information

The quantity describes the catalogue variant, not a dosing or administration recommendation.

Documentation and artwork

Owner-authorized generic catalogue artwork is not a photograph of a specific batch and does not establish purity, testing or certification. No verified batch-linked COA is provided. Storage and handling information awaits actual supplier documentation; no unverified temperature or expiry is stated.

This is an informational catalogue entry. Orders are not accepted. No instructions for human or veterinary use are provided.

Research context

GHRH analogue peptide

  • Endocrine research
  • Lipid metabolism research

Substance research context; not a claim of efficacy or approval for this product.

Tesamorelin is a GHRH analogue, not growth hormone itself. EMA describes stimulation of growth-hormone release, while trials measured IGF-1. Hormonal and abdominal-fat endpoints are not proof of general health benefit. A growth-hormone-releasing-factor analogue is evaluated in a specific clinical context; biomarkers are not a universal suitability measure.

Study types in selected sources: Other human studies · Phase III

Preclinical findings are not clinical efficacy evidence. Human findings concern the studied preparation, not this supplier product.

Scientific profile and evidence limitations

Product specifications

CAS
Unknown
Formula
Unknown
Molecular weight
Unknown
Purity result
No verified purity result is available.
Storage
Storage information is not yet available.

Documents and batches

Batch documentation is not yet available.

View laboratory records

Compound information

TESAMORELIN – vial

Educational substance profile

Research and references

Scientific references are not yet available.

Educational substance profile

Shipping & support

Contact support for delivery information.

Support & shipping

Other approved catalogue options

VESTRIK

Welcome to VESTRIK

This website provides a product catalogue and scientific and educational information. Before continuing, read the terms and select all four acknowledgements.

This acknowledgement is not a purchase contract and does not override product restrictions or legal requirements.

Read the terms in this window

Updated 2026-10-12. Orders and payments are currently unavailable. All catalogue products are out of stock. These purchase terms apply only to lawfully offered products when sales are enabled; this text does not activate sales.

Seller and contact

UAB Aromagama, company code 305243105, VAT LT100012643616. Registered office and returns address: Mokolų g. 5, LT-68172 Marijampolė, Lithuania. Email: uab.aroma.gama@gmail.com. Phone: +37068935779.

Ordering and contract formation

Once sales are enabled, the buyer selects an available product and variant, reviews quantity, contact details, delivery, total cost and payment method, reads these terms and accepts them before payment. An order is the buyer’s offer to purchase; the contract is formed when the seller confirms acceptance by email. An automatic acknowledgement or B2B enquiry alone is not acceptance. The confirmation provides the contract terms in a format that can be saved. This sales process is currently inactive.

Prices and payment

Catalogue prices are in euros (EUR). Approved retail prices include VAT; the final total and delivery charge must be disclosed before an obligation to pay is assumed. VESTRIK currently accepts no payments: no purchasing payment methods are active. MakeCommerce is the intended processor, but the VESTRIK integration has not been activated. Bank or card methods will be offered only following provider approval and activation of the particular methods. Naming a platform does not mean all its methods will be available.

Shipping

No orders are currently dispatched. The EU warehouse is in Lithuania. Planned dispatch is within 1 business day; delivery to European countries typically takes 5–10 business days, without a guaranteed deadline. Dispatch and carrier delivery are separate stages. The Lithuania shipping option is configured at EUR 5.99 below EUR 250 and free from EUR 250; the previous EUR 40 threshold has been replaced. The existing EUR 17 international technical rate is unchanged; final international destinations, carriers and rates remain subject to approval. Sales remain unavailable. Discount interactions and checkout shipping eligibility must be tested before sales begin. Confirmed methods and charges will be displayed before payment.

Consumer withdrawal and refunds

A consumer normally has 14 days after receiving goods to notify withdrawal from a distance contract, then 14 days to return them. Email the seller with the order number and a clear withdrawal statement; use the returns address above. The buyer bears direct withdrawal return shipping costs. Rights concerning defective goods are unaffected.

The amount paid and standard outbound delivery charge are refunded within 14 days of notice, using the original method unless otherwise agreed without a fee. The seller may withhold repayment until receiving the goods or evidence of dispatch. An extra charge for a more expensive chosen delivery method is not refunded.

Exceptions apply only where the actual goods meet statutory conditions—for example, unsealed goods unsuitable for return for health-protection or hygiene reasons. “Peptide”, “research” or “syringe” labels alone do not create an exception. Actual packaging and characteristics require assessment; there is no catalogue-wide returns exclusion. Mandatory remedies for defects remain.

Complaints

Contact the seller in writing or by email, stating the requested remedy and purchase details. A reasoned response is provided within 14 calendar days. Unresolved disputes may be referred to VVTAT or a court. Mandatory consumer rights are preserved.

Product-specific restrictions

The catalogue contains peptide and biochemical compounds in different presentations and insulin syringes; retatrutide and tirzepatide categories are not concealed. Sale eligibility, intended use and claims require individual approval. A listing, zero stock or an 18+ acknowledgement does not authorize sale. Scientific profiles are neither specific-batch analysis nor treatment advice. VESTRIK is not exclusively B2B or laboratory-only and currently enforces no such customer restriction. Sales of unapproved or restricted products are not enabled.

Open the terms page (new window)
Leave Website

A first-party cookie remembers the acknowledgement for 30 days. This is not verification of identity, age or professional qualifications. Cookie consent is managed separately; this action does not grant analytics or marketing consent.

Privacy